Estimated read time: Less than a minute
This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.
ALBUQUERQUE, N.M. (AP) — An Albuquerque company which markets diagnostic tests for lupus and other autoimmune rheumatoid diseases has filed for an initial public offering.
The Albuquerque Journal reports (http://goo.gl/gYe4Mf) that Exagen Diagnostics Inc. recently filed its registration statement with the U.S. Securities and Exchange Commission.
Exagen President and CEO Ron Rocca says the company has to wait for around three weeks and then officials will visit with bankers and investors.
Exagen uses software to identify key genomic biomarkers to better diagnose and treat disease. It released its first lupus test in January 2012.
Launched in 2002, the company has raised about $40 million in venture capital, including about $6 million from Sun Mountain Capital in Santa Fe.
Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
